3192 results for «730»
3192 results
Opening ceremony
08 Apr 2017 – From PCR Tokyo Valves 2017
Closing Ceremony and Awards
09 Apr 2017 – From PCR Tokyo Valves 2017
PCR London Valves 2017 Opening Ceremony - Welcome address
25 Sep 2017 – From PCR London Valves 2017
Welcome to Imaging Day
24 Sep 2017 – From PCR London Valves 2017
Welcome and introduction to PCR Innovators Day London
24 Sep 2017 – From PCR Innovators Day 2017
AsiaPCR/SingLIVE 2018: Closing Ceremony and Awards
27 Jan 2018 – From AsiaPCR/SingLIVE 2018
Join U. Kaul, T.H. Koh and S.T. Lim for the AsiaPCR/SingLIVE 2018 Closing Ceremony if you want to find out who this year's Best Abstract and Best Clinical case award winners are?
Femoral artery pseudoaneurysm expansion managed through subcutaneous fat embolization
06 Apr 2021
Femoral artery pseudoaneurysm is a known complication following cardiac catheterization. Rarely, expansion of the pseudoaneurysm can occur and is often catastrophic. We describe a unique method employed by our centre to deal with such a complication.
Author
PCR @ TCT 2024 - Get the international perspective!
27 Oct 2024
Thanks to the contribution of a team of interventional cardiologists from around the globe, get the international perspective on Late-breaking Clinical Trials and Science released at TCT 2024 - check out the list below.
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)
01 Apr 2025
Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.
Author
PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial
18 May 2021
Transcatheter aortic valve implantation (TAVI) offers an effective, less invasive therapeutic alternative to surgical aortic valve replacement in patients with symptomatic, severe aortic stenosis. Although TAVI is demonstrated to be superior to medical therapy or surgery in patients who are at prohibitive or high risk for...
The PROTECTED TAVR study: Cerebral embolic protection during transcatheter aortic valve replacement
18 Sep 2022
Jonathan Curio provides his take on the PROTECTED TAVR study which was presented by Samir R. Kapadia at TCT 2022. The aim was to evaluate whether TAVR with cerebral embolic protection would reduce the rate of clinical stroke in transfemoral TAVR.
Author
Transcatheter vs surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut Low Risk trial
05 Mar 2023
Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.
Author
